Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: A pooled analysis of 6 studies

European Neuropsychopharmacology

Volumn 18, Issue 6, 2008, Pages 422-430

  Stein, Dan J ^a   Baldwin, David S ^b   Baldinetti, Francesca ^c   Mandel, Francine ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c PFIZER INC   (United States)

Author keywords

Comorbid depressive symptoms; Efficacy; GAD; Generalized anxiety disorder; Pregabalin

Indexed keywords

ALPRAZOLAM; ESCITALOPRAM; FLUOXETINE; LORAZEPAM; PLACEBO; PREGABALIN; VENLAFAXINE; ZOLPIDEM;

ADULT; AGED; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; COMORBIDITY; DISABILITY; DRUG EFFICACY; DYSTHYMIA; FEMALE; GENERALIZED ANXIETY DISORDER; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; INSOMNIA; MAJOR DEPRESSION; MALE; POST HOC ANALYSIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTICONVULSANTS; ANXIETY; CLINICAL TRIALS AS TOPIC; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEX FACTORS; TREATMENT OUTCOME;

EID: 42749093852     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2008.01.004     Document Type: Article

References (60)